Hatylas Z. Azevedo
Sao Paulo, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
LncRNA Dlx4os drives malignant transformation and phenotype switching in melanoma.
Journal: Epigenetics
Published: March 19, 2026
Discovery and optimization of diarylsulfone-based dual M3-Antagonists and β2-Agonists (MABAs) as inhaled bronchodilators.
Journal: European journal of medicinal chemistry
Published: February 24, 2026
Validation of an RP-HPLC method for simultaneously quantifying three UV filters encapsulated into nanostructured lipid carriers.
Journal: Analytical methods : advancing methods and applications
Published: February 11, 2026
Proteomic Profiling of Non-Muscle Invasive Bladder Cancer Reveals Potential Biomarkers for Recurrence and Progression Risk.
Journal: Journal of proteome research
Published: January 26, 2026
Design, Optimization, and Biological Evaluation of First-in-Class Triple Inhibitors of SGLT1, SGLT2, and DPP4 for Type 2 Diabetes Mellitus.
Journal: Journal of medicinal chemistry
Published: December 12, 2025
Novel Dihydropteridinone Derivatives As Potent Inhibitors of the Understudied Human Kinases Vaccinia-Related Kinase 1 and Casein Kinase 1δ/ε.
Journal: Journal of medicinal chemistry
Published: May 23, 2024
NLC-Based Sunscreen Formulations with Optimized Proportion of Encapsulated and Free Filters Exhibit Enhanced UVA and UVB Photoprotection.
Journal: Pharmaceutics
Published: February 02, 2024
CACHE (Critical Assessment of Computational Hit-finding Experiments): A public-private partnership benchmarking initiative to enable the development of computational methods for hit-finding.
Journal: Nature reviews. Chemistry
Published: July 05, 2022
Discovery of novel benzothiophene derivatives as potent and narrow spectrum inhibitors of DYRK1A and DYRK1B.
Journal: Bioorganic & medicinal chemistry letters
Published: January 31, 2022
Genome-wide promoter methylation profiling in a cellular model of melanoma progression reveals markers of malignancy and metastasis that predict melanoma survival.
Journal: Clinical epigenetics
Published: January 07, 2022
Last Updated: 09/26/2026